A Study of Response Adapted Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Marginal Zone Lymphoma

NCT05929612 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

RADIATION: Ultra Low Dose 4 Gy Radiation

Sponsor

M.D. Anderson Cancer Center